Discover
ACTU
Actuate Therapeutics, Inc. Common stock
1.44
2 x 1.50
1 x 1.53
bid
ask
-
0.09
5.88%
2 @ 04:00 AM
1.45 +0.01 (0.69%)
| Ytd | -76.47% | |
| 1y | -76.51% |
1.40
day range
1.55
1.40
52 week range
9.22
| Open | 1.54 | Prev Close | 1.53 | Low | 1.40 | High | 1.55 | Mkt Cap | 34.45M |
| Vol | 134.73K | Avg Vol | 181.05K | EPS | -0.98 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.49 | Inst. Own | 53.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.35 | 200-d Avg | 4.60 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | AWM Investment Company, Inc. | 139.51K | 1.05M | 0.71% |
| 2024-09-29 | Long Corridor Asset Management Ltd | 125.00K | 941.25K | 0.64% |
| 2024-09-29 | Royal Bank of Canada | 35.30K | 265.81K | 0.18% |
| 2024-09-29 | Geode Capital Management, LLC | 27.89K | 210.03K | 0.14% |
| 2024-09-29 | Northwestern University | 27.78K | 209.17K | 0.14% |
| 2024-09-29 | KG&L Capital Management,LLC | 12.00K | 90.36K | 0.06% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 16.16K | 121.67K | 0.08% |
| 2024-10-30 | Fidelity Total Market Index Fund | 5.49K | 41.35K | 0.03% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 3.85K | 29.01K | 0.02% |